SCHEMBL23748059

SCHEMBL23748059

CCSc1c(-c2nc3cc(C(F)(F)C(F)(F)F)nnc3n2C)ncn1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21837111 0.91 POLB (0.32) —
SCHEMBL30080318 0.83 — —
SCHEMBL23748078 0.83 — —
SCHEMBL23748067 0.83 — —
SCHEMBL30080647 0.81 — —
SCHEMBL23748048 0.80 LMNA (0.34) —
SCHEMBL24183774 0.80 — —
Hydrochloric Acid SCHEMBL30080662 0.79 — —
SCHEMBL31003477 0.78 — —
SCHEMBL25886946 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112867713-B Process for preparing imidazole derivatives 拜耳公司 2023-05-05 — — CN disclosed
EP-3864016-B1 PROCESS FOR PREPARING SUBSTITUTED IMIDAZOLE DERIVATIVES BAYER AG (DE) 2022-09-14 — — EP disclosed
US-20220009930-A1 PROCESS FOR PREPARING IMIDAZOLE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2022-01-13 — — US disclosed
US-20210380611-A1 PROCESS FOR PREPARING SUBSTITUTED IMIDAZOLE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2021-12-09 — — US disclosed
EP-3864016-A1 PROCESS FOR PREPARING SUBSTITUTED IMIDAZOLE DERIVATIVES Bayer Aktiengesellschaft (DE) 2021-08-18 — — EP disclosed
EP-3864015-A1 PROCESS FOR PREPARING IMIDAZOLE DERIVATIVES Bayer Aktiengesellschaft (DE) 2021-08-18 — — EP disclosed
Send feedback